Vol. 7 (09) pp. 238-241 DOI: 10.21474/IJAR01/9652

DRESS INDUCED BY DAPSONE : A RARE LIFE - THREATENING COMPLICATION OF DAPSONE TREATMENT.

, and
  • Service de Dermatologie-V?n?rologie, CHU Mohamed VI, Universit? Cadi-Ayyad, Marrakech-Maroc.
24 Downloads 122 Views
Crossref

Download Full Paper (PDF)

Abstract

Dapsone is widely used for a variety of infectious, immune and hypersensitivity disorders. However, the use of dapsone may be associated with a plethora of adverse effects, whose DRESS syndrome potentially deadly. We report the clinical case of a 22 years old woman who was treated by Disulone ? 100mg/day for lichen pigmentosus. 3 weeks later, she presented a DRESS syndrome with Dapsone, successfully managed by oral steroids. The aim of this work was to highlight the main features of DRESS syndrome with Dapsone, through a systematic review of cases published in the medical literature, to enable rapid diagnosis and appropriate management of this syndrome

Keywords

How to Cite This Article

Zineb Rachadi, OuafaHocar and Said Amal. (2019); DRESS INDUCED BY DAPSONE : A RARE LIFE - THREATENING COMPLICATION OF DAPSONE TREATMENT., International Journal of Advanced Research (IJAR), 7 (09), 238-241, ISSN 2320-5407. DOI: https://doi.org/10.21474/IJAR01/9652

Corresponding Author

Zineb RACHADI
Service de Dermatologie-Vénérologie, CHU Mohamed VI, Université Cadi-Ayyad, Marrakech-Maroc

Article Analytics

References

  1. Farhi, E.B?gon, P.Wolkenstein, O. Chosidow. Dapsone (Disulone?) en dermatologie. EMC - Dermatologie-Cosm?tologie, Volume 2, Issue 2, May 2005, Pages 103-117
  2. Balaji O, Amita D, George MM, Meena Kumari K, Mohan Babu Vittalrao A.
  3. Dapsone induced-Dress : A case report. Asian Journal of Pharmaceutical and Clinical Research.? Vol 10, Issue 5 (2017) 4-5.
  4. Ozeki , T. Mushiroda, A. Yowang, A. Takahashi, M. Kubo, Y. Shirakata, Z. Ikezawa,M. Iijima, T. Shiohara, K. Hashimoto, N, Kamatani, Y. Nakamura. Genome-wideassociation study identifies HLA-A*3101 allele as a genetic risk factor forcarbamazepine-induced cutaneous adverse drug reactions in Japanese population. Hum
  5. Mol Genet. 20 (2011) 1034?1041.
  6. Chen W-T, Wang C-W, Lu C-W, Chen C-B, Lee H-E, Hung S-I, Choon S-E,Yang C-H, Liu M-T, Chen TJ, Fan W-L, Su S-C, Lin YY-W, Chang Y-C, Chung W-H. Taiwan Severe Cutaneous Adverse Reaction Consortium, The function of HLA-B*13:01 involved in the pathomechanism of dapsone-induced severe cutaneous adverse reactions. The Journal of Investigative Dermatology (2018). doi: 10.1016/j.jid.2018.02.004.
  7. Watanabe Hideaki, Watanabe Yurie, TashiroYasuya, Mushiroda Taisei, Ozeki Takeshi, Hashizume Hideo, SuekiHirohiko, Yamamoto Toshinori, Utsunomiya-Tate Naoko, Gouda Hiroaki, Kusakabe Yoshio. A docking model of dapsone bound to HLA-B*13:01 explains therisk of dapsone hypersensitivity syndrome. Journal of Dermatological Science 2018.http://dx.doi.org/10.1016/j.jdermsci.2017.08.007
  8. Na Wang, LeelaParimi, Hong Liu, Furen Zhang.? A Review on Dapsone Hypersensitivity Syndrome Among Chinese Patients with an Emphasis on Preventing Adverse Drug Reactions with Genetic Testing. Am. J. Trop. Med. Hyg., 96(5), 2017, pp. 1014-1018
  9. Shiohara T, Iijima M, Ikezawa Z, Hashimoto K. The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations. Br J Dermatol 2007;156:1083?4.
  10. Vincent Descamps, Sylvie Ranger-Rogez, Philippe Musette, AnnickBarbaud. Le DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms). Revue du rhumatisme monographies 78 (2011) 197?200
  11. Descamps V, Ben Sa?d B, Sassolas B, etal.Priseencharge du Drug Reactionwith Eosinophilia and Systemic Symptoms. Ann DermatolVenereol 2010;137:703?8.
  12. Kardaun SH, Sidoroff A, Valeyrie-Allanore L, Halevy S, Davidovici BB, Mockenhaupt M, et al. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: Does a DRESS syndrome really exist?. Br J Dermatol 2007;156(3):609-11.
  13. Aneseya P. Varghese ,Deepthi R.V. , VijayaShenoy , Seema Pavaman. Dapsone hypersensitivity syndrome : a case report. NUJHS Vol. 4, No.3, September 2014, ISSN 2249-7110
  14. Sener, L Doganci, M Safali, B Besirbellioglu, F Bulucu, APahsa. Severe Dapsone Hypersensitivity Syndrome. J InvestigAllergolClinImmunol 2006; Vol. 16(4): 268-270
  15. Aota N, Shiohara T. Viral connection between drug rashes and autoimmune diseases: how autoimmune responses are generated after resolution of drug rashes. Autoimmun Rev 2009;8:488?94.

Similar Articles

Creative Commons Attribution 4.0 This work is licensed under a Creative Commons Attribution 4.0 International License.